Annual Current Assets
$493.11 M
-$241.04 M-32.83%
31 December 2023
Summary:
Supernus Pharmaceuticals annual total current assets is currently $493.11 million, with the most recent change of -$241.04 million (-32.83%) on 31 December 2023. During the last 3 years, it has fallen by -$137.30 million (-21.78%). SUPN annual current assets is now -32.83% below its all-time high of $734.15 million, reached on 31 December 2022.SUPN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$640.00 M
+$49.00 M+8.29%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly total current assets is currently $640.00 million, with the most recent change of +$49.00 million (+8.29%) on 30 September 2024. Over the past year, it has increased by +$190.64 million (+42.43%). SUPN quarterly current assets is now -27.55% below its all-time high of $883.34 million, reached on 31 March 2023.SUPN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.8% | +42.4% |
| 3 y3 years | -21.8% | -4.2% |
| 5 y5 years | -0.1% | +49.9% |
SUPN Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.8% | at low | -27.6% | +51.1% |
| 5 y | 5 years | -32.8% | +4.3% | -27.6% | +51.1% |
| alltime | all time | -32.8% | +1138.5% | -27.6% | +2469.3% |
Supernus Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $640.00 M(+8.3%) |
| June 2024 | - | $591.00 M(+8.6%) |
| Mar 2024 | - | $544.32 M(+10.4%) |
| Dec 2023 | $784.56 M(-19.0%) | $493.11 M(+9.7%) |
| Sept 2023 | - | $449.36 M(+6.1%) |
| June 2023 | - | $423.54 M(-52.1%) |
| Mar 2023 | - | $883.34 M(+20.3%) |
| Dec 2022 | $968.36 M(-11.0%) | $734.15 M(+10.6%) |
| Sept 2022 | - | $663.89 M(+6.2%) |
| June 2022 | - | $625.12 M(+10.0%) |
| Mar 2022 | - | $568.52 M(-5.5%) |
| Dec 2021 | $1.09 B(+24.5%) | $601.59 M(-10.0%) |
| Sept 2021 | - | $668.38 M(+4.6%) |
| June 2021 | - | $639.24 M(+9.1%) |
| Mar 2021 | - | $586.02 M(-7.0%) |
| Dec 2020 | $873.68 M(+27.1%) | $630.42 M(+14.2%) |
| Sept 2020 | - | $552.01 M(-0.9%) |
| June 2020 | - | $557.15 M(+0.0%) |
| Mar 2020 | - | $557.05 M(+17.9%) |
| Dec 2019 | $687.64 M(+42.0%) | $472.64 M(+10.7%) |
| Sept 2019 | - | $427.08 M(+9.3%) |
| June 2019 | - | $390.91 M(-6.9%) |
| Mar 2019 | - | $419.97 M(-14.9%) |
| Dec 2018 | $484.32 M(+147.1%) | $493.49 M(+26.4%) |
| Sept 2018 | - | $390.56 M(+37.3%) |
| June 2018 | - | $284.52 M(-51.2%) |
| Mar 2018 | - | $583.25 M(+155.3%) |
| Dec 2017 | $196.01 M | $228.45 M(+19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $191.33 M(+15.6%) |
| June 2017 | - | $165.49 M(+10.5%) |
| Mar 2017 | - | $149.76 M(-1.1%) |
| Dec 2016 | $158.16 M(+91.3%) | $151.40 M(+9.6%) |
| Sept 2016 | - | $138.20 M(+21.1%) |
| June 2016 | - | $114.14 M(+21.5%) |
| Mar 2016 | - | $93.95 M(-11.3%) |
| Dec 2015 | $82.68 M(+194.7%) | $105.95 M(+3.3%) |
| Sept 2015 | - | $102.55 M(-3.0%) |
| June 2015 | - | $105.74 M(+4.2%) |
| Mar 2015 | - | $101.50 M(-6.6%) |
| Dec 2014 | $28.06 M(+102.8%) | $108.73 M(+5.6%) |
| Sept 2014 | - | $102.97 M(+43.0%) |
| June 2014 | - | $71.98 M(-9.9%) |
| Mar 2014 | - | $79.93 M(-17.7%) |
| Dec 2013 | $13.83 M(+447.4%) | $97.16 M(-5.5%) |
| Sept 2013 | - | $102.86 M(-7.0%) |
| June 2013 | - | $110.62 M(+44.9%) |
| Mar 2013 | - | $76.33 M(-16.5%) |
| Dec 2012 | $2.53 M(-41.7%) | $91.46 M(+45.4%) |
| Sept 2012 | - | $62.89 M(-19.2%) |
| June 2012 | - | $77.81 M(+102.5%) |
| Mar 2012 | - | $38.42 M(-22.2%) |
| Dec 2011 | $4.33 M(-39.8%) | $49.40 M(+98.3%) |
| Sept 2011 | - | $24.91 M(-37.4%) |
| Dec 2010 | $7.20 M(+2.5%) | $39.81 M(-22.3%) |
| Sept 2010 | - | $51.24 M(-29.7%) |
| Dec 2009 | $7.02 M(-8.6%) | $72.88 M |
| Dec 2008 | $7.68 M | - |
FAQ
- What is Supernus Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual current assets year-on-year change?
- What is Supernus Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly current assets year-on-year change?
What is Supernus Pharmaceuticals annual total current assets?
The current annual current assets of SUPN is $493.11 M
What is the all time high annual current assets for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual total current assets is $734.15 M
What is Supernus Pharmaceuticals annual current assets year-on-year change?
Over the past year, SUPN annual total current assets has changed by -$241.04 M (-32.83%)
What is Supernus Pharmaceuticals quarterly total current assets?
The current quarterly current assets of SUPN is $640.00 M
What is the all time high quarterly current assets for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly total current assets is $883.34 M
What is Supernus Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, SUPN quarterly total current assets has changed by +$190.64 M (+42.43%)